LiDCO appoints Peter Grant as chairman designate
It is the Board's intention that Mr. Grant will be appointed as Chairman of the Board.
Mr. Grant was Chief Executive Officer of Skyepharma Plc from January 2012 to June 2016 until its merger with Vectura Group plc. He joined Skyepharma as Chief Financial Officer in November 2006.
Prior to Skyepharma, Mr. Grant held board positions as Interim Chief Executive Officer at Voice Commerce Group, Group Finance Director at Eurodis Electron PLC, Chief Financial Officer at WorldPay plc and Finance Director then Group Chief Executive at Molins PLC.
Prior to this Mr. Grant held a variety of senior commercial, financial and general management roles in the General Electric Company PLC group of companies.
He holds an MA in Mathematics from the University of Oxford and is a Chartered Accountant.
Mr. Grant is currently Non-Executive Director and Chair of the Audit and Risk Committee at Abzena plc, an AIM quoted life sciences group providing services and technologies enabling the development and manufacture of biopharmaceutical products.
On his appointment, Mr. Grant will be a member of the Audit, Nomination and Remuneration Committees of the Company.
Jill McGregor is joining the Board as Chief Financial Officer, taking up her appointment no later than 3 July 2017.
Ms. McGregor is a Chartered Accountant and has over 25 years' experience in a number of finance roles.
Ms. McGregor joins LiDCO after six years as Chief Financial Officer of Touch Bionics.
Prior to this, she spent seven years at Optos plc, a provider of retinal imaging devices, as Group Financial Controller and then as Vice President and Director of Finance.
Both Ms. Wallis and Mr. Brown intend to step down at the 2017 Annual General Meeting after being on the board for 14 and 11 years respectively.